13 November 2023
| Title | Name | Time | Session type |
| The Socio-Economic Value of Adult Immunization: Results from a Comprehensive Literature Review of Four Immunization Programs in Ten Countries | Hania El Banhawi | Poster Session Time: 10:30 – 13:30 Discussion Period: 12:30 – 13:30 |
Poster Session |
| Is Stedi Steady? an Exploration of the Uncertainties Underlying the Quantification of the Broader Value of Antibiotics | Simon Brassel | Poster Session Time: 15:30 – 18:30 Discussion Period: 16:00 – 17:00 |
Poster Session |
| Issues Regarding Pricing and Access to Gene and Advanced Therapy Medicinal Products | Lotte Steuten (panelist) | 10:15-11:15 | Issue Panel |
14 November 2023
| Title | Name | Time | Session type |
| Is Payment Innovation Keeping Up With Therapy Innovation? A New Taxonomy of Innovative Payment Solutions to Aid Effective Implementation | Frederick McElwee | Poster time: 10:30-13:30 Discussion period: 12:30-13:30 |
Poster Session |
| Health Technology Assessment of Multiple Myeloma Therapies: Value Demonstration and Value Recognition Challenges | Nadine Henderson | Poster time: 10:30-13:30 Discussion period: 12:30-13:30 |
Poster Session |
| Setting the Right Discount Rate for Health Technology Assessment in the Slovak Republic | Patricia Cubi-Molla | Poster time: 10:30-13:30 Discussion period: 12:30-13:30 |
Poster Session |
| What Should Value Assessment of New Antibiotics Look like in the Context of Pull Incentives? The How, What, and Where Next for Antimicrobial Resistance and Health Technology Assessment | Grace Hampson | 10:15 – 11:15 | Spotlight Session |
| Pathways to ISPOR Leadership | Lotte Steuten | 11:30 – 12:00 | Fast Facts |
| An Eye for the Future: Does an Interdisciplinary View Help Improve Discounting Approaches for Curative Gene Therapies? | Grace Hampson (panellist) Simon Brassel (moderator) |
15:15 – 16:15 | Educational Session |
| Charting a Greener Future: Should Environmental Impact Factor into HTA Evaluations? | Nadine Henderson (panellist) Grace Hampson (moderator) |
17:00-18:00 | Panel Discussion |
15 November 2023
| Title | Name | Time | Session type |
| The Race to Improve Health Technology Assessment of Gene Therapies: Which Countries Are Embracing Recommendations? | Sian Besley | Poster Session Time: 9:00 -11:30 Discussion Period: 9:00 -10:00 |
Poster Session |
| Pricing Pharmaceuticals for the Common Good: Is Value-Based Pricing Still the Right Solution? | Eleanor Bell (panellist) Mikel Berdud (moderator) |
08:00 – 09:00 | Issue Panel |
| Long-Term Tracking of Clinical Effectiveness, Safety, and Value of Gene Therapies and Implications for EU Joint Clinical Assessment: Multistakeholder Perspectives From Patients, Manufacturers, and Payers | Martina Garau (chair) | 08:00 – 09:00 | Issue Panel |
| Lessons from the COVID-19 Vaccines Taskforce | Eleanor Bell | Poster session: 8:30-10:00 Discussion period: 9:10 |
Poster Session |
Register here to join OHE at ISPOR: ISPOR – Registration Information